{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:04:07Z","timestamp":1790744647586,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jpba.2023.115613","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T11:29:33Z","timestamp":1690802973000},"page":"115613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Analytical method development, validation, and out-of-specification investigations for polyethylene glycol"],"prefix":"10.1016","volume":"235","author":[{"given":"Tyler C.","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaosheng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2023.115613_bib1","unstructured":"The United States Pharmacopeia, Official Monograph for Polyethylene Glycol. \u3008https:\/\/www.uspnf.com\u3009 (USP-NF online, The United States Pharmacopeial Convention)."},{"key":"10.1016\/j.jpba.2023.115613_bib2","unstructured":"The European Pharmacopoeia, Official Monograph for Macrogols. \u3008https:\/\/pheur.edqm.eu\/home\u3009 (European Pharmacopoeia online, EDQM Council of Europe)."},{"key":"10.1016\/j.jpba.2023.115613_bib3","unstructured":"Poly(Ethylene Glycol) Chemistry, Biotechnical and Biomedical Applications. Edited by J. Milton Harris. In the book series \u201cTopics in Applied Chemistry\u201d. Copyright: Springer Science+Business Media New York 1992. Publisher: Springer New York, NY."},{"key":"10.1016\/j.jpba.2023.115613_bib4","unstructured":"Poly(ethylene glycol), Chemistry and Biological Applications. Edited by J. Milton Harris, Samuel Zalipsky, ACS Symposium Series Volume 680, American Chemical Society, Washington, DC, 1997."},{"key":"10.1016\/j.jpba.2023.115613_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"50","key":"10.1016\/j.jpba.2023.115613_bib6","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1073\/pnas.1616639113","article-title":"Supramolecular PEGylation of biopharmaceuticals","volume":"113","author":"Webber","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.jpba.2023.115613_bib7","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1021\/acs.oprd.0c00273","article-title":"Drug development through modification of small molecular drugs with monodisperse poly(ethylene glycol)s","volume":"24","author":"Tingjuan","year":"2020","journal-title":"Org. Process Res. Dev."},{"issue":"36","key":"10.1016\/j.jpba.2023.115613_bib8","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"2","key":"10.1016\/j.jpba.2023.115613_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jconrel.2011.10.037","article-title":"State of the art in PEGylation: the great versatility achieved after forty years of research","volume":"161","author":"Gianfranco","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2023.115613_bib10","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.3390\/polym14194195","article-title":"Design strategies for and stability of mRNA\u2013lipid nanoparticle COVID-19 vaccines","volume":"14","author":"Liu","year":"2022","journal-title":"Polymers"},{"issue":"11","key":"10.1016\/j.jpba.2023.115613_bib11","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Rumiana Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.jpba.2023.115613_bib12","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/jps.2600731023","article-title":"Degradation of fenprostalene in polyethylene glycol 400 solution","volume":"73","author":"Johnson","year":"1984","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2023.115613_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.trac.2017.11.003","article-title":"Reactive impurities in large and small molecule pharmaceutical excipients \u2013 a review","volume":"101","author":"Kelly","year":"2018","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2023.115613_bib14","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1208\/s12249-011-9677-z","article-title":"Reactive impurities in excipients: profiling, identification and mitigation of drug\u2013excipient incompatibility","volume":"12","author":"Wu","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jpba.2023.115613_bib15","unstructured":"ICH M7(R1) Assessment and Control of DNA Reactive (Mutagenic) Impurities In Pharmaceuticals to Limit Potential Carcinogenic Risk (Current Step 4 version, dated 31 March 2017). \u3008https:\/\/www.ich.org\/page\/multidisciplinary-guidelines\u3009."},{"key":"10.1016\/j.jpba.2023.115613_bib16","unstructured":"Immediately Dangerous to Life Or Health Concentrations (IDLH): Methyl formate (May 1994) \u3008https:\/\/www.cdc.gov\/niosh\/idlh\/107313.html\u3009."},{"key":"10.1016\/j.jpba.2023.115613_bib17","unstructured":"ICH Q3C(R8) Impurities: Guideline for Residual Solvents (Current Step 4 version dated 22 April 2021) \u3008https:\/\/www.ich.org\/page\/quality-guidelines\u3009."},{"key":"10.1016\/j.jpba.2023.115613_bib18","unstructured":"ICH Guideline Q2(R1) Validation of Analytical Procedures: Text and Methodology (Complementary Guideline on Methodology dated 6 November 1996 incorporated in November 2005) Current Step 4 version, Parent Guideline dated 27 October 1994 \u3008https:\/\/www.ich.org\/page\/quality-guidelines\u3009."},{"issue":"9","key":"10.1016\/j.jpba.2023.115613_bib19","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/jps.23198","article-title":"Formation of reactive impurities in aqueous and neat polyethylene glycol 400 and effects of antioxidants and oxidation inducers","volume":"101","author":"Hemenway","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jpba.2023.115613_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/PDT-120002237","article-title":"Stabilization of pharmaceuticals to oxidative degradation","volume":"7","author":"Waterman","year":"2002","journal-title":"Pharm. Dev. Technol."},{"issue":"4","key":"10.1016\/j.jpba.2023.115613_bib21","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jps.21119","article-title":"N\u2010methylation and N\u2010formylation of a secondary amine drug (varenicline) in an osmotic tablet","volume":"97","author":"Kenneth","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.jpba.2023.115613_bib22","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/jps.23198","article-title":"Formation of reactive impurities in aqueous and neat polyethylene glycol 400 and effects of antioxidants and oxidation inducers","volume":"101","author":"Hemenway","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"13","key":"10.1016\/j.jpba.2023.115613_bib23","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1021\/ja00507a023","article-title":"Mechanism of the Cannizzaro reaction","volume":"101","author":"Swain","year":"1979","journal-title":"J. Am. Chem. Soc."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:31:08Z","timestamp":1760002268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523003825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":23,"alternative-id":["S0731708523003825"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115613","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical method development, validation, and out-of-specification investigations for polyethylene glycol","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115613"}}